Market research
CMP.AU Compumedics Limited
AU AUD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 48M
- P/E ratio
- Not available
- Analyst target
- 0.65
- Dividend yield
- Not available
- Beta
- 0.39
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- AU000000CMP2
- Market cap
- 48M
- P/E ratio
- Not available
- Analyst target
- 0.65
- Dividend yield
- Not available
- Beta
- 0.39
About
About Compumedics Limited
Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and associated technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. The company provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon HST; and Somté, an investigative tool. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG, Grael 4K-EEG, and Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Okti, a portable EEG amplifier; and Siesta 802, a multi-functional ambulatory recording device. In addition, it provides software products, such as Profusion Sleep software suite; Profusion EEG Software; Profusion neXus 360, a web-based patient data and lab management system that offers integrated hardware and software solutions for sleep and neurology clinics; CURRY, a signal processing and source localization multi-modal neuroimaging suite; Profusion neXus Scheduler for planning for staff and time; Somte and Persyst Software; HD Digital Video; Profusion Plus; ECG Free software; and TCM5 FLEX Transcutaneous Monitor, Grael DC, Siesta extended battery pack, and Summit IP products. Further, the company offers brain research technologies; pharmaceutical clinical trials and research services; and consumables and supplies for diagnostic and research solutions. The company was incorporated in 1987 and is headquartered in Abbotsford, Australia.
Research context
Compumedics Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the CMP.AU discussion.
5 years, 6 months ago
Compumedics Limited is currently in a long term downtrend where the price is trading 9.8% below its 200 day moving average.
From a valuation standpoint, the stock is 99.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.4.
Compumedics Limited's total revenue sank by 1.4% to $18M since the same quarter in the previous year.
Its net income has increased by 717.4% to $1M since the same quarter in the previous year.
Finally, its free cash flow grew by 103.4% to $73K since the same quarter in the previous year.
Based on the above factors, Compumedics Limited gets an overall score of 3/5.